糖类和输送途径影响大鼠的胰岛素和依赖葡萄糖的胰岛素型多反应
A Valentina Nisi1, Myrtha M L Arnold2, Ginger D Blonde1
1Department of Psychology and Program in Neuroscience, Florida State University, Tallahassee, Florida, United States.
概括
在老鼠中,口服葡萄糖的摄入会触发较快的胰岛素释放,而不是胃输送. 这种新的制剂突出显示了葡萄糖.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 动物模型 动物模型
背景情况:
- 了解口腔刺激在内分泌反应中的作用对于代谢研究至关重要.
- 以前的方法缺乏精度,无法区分口服与胃营养效应.
研究的目的:
- 开发和验证一种用于精确测量口服刺激内分泌反应的老鼠模型.
- 为了比较口内 (IO) 与胃内 (IG) 葡萄糖和果糖对胰岛素和GIP分泌的影响.
主要方法:
- 使用了一种新型的老鼠制剂,配备了双IO和IG导管和关静脉导管.
- 输注1.0M葡萄糖或果糖通过IO和IG路线进行了1或10分钟的输注.
- 测量了血胰岛素,依赖葡萄糖的胰岛素型多 (GIP) 和葡萄糖水平.
主要成果:
- 与胃输送相比,口服葡萄糖的输送引起了与胃输送相比,血胰岛素的显著更大和更早的上升.
- 10分钟的口内葡萄糖输液增加了依赖葡萄糖的胰岛素型多 (GIP) 水平,比胃内输液更多.
- 口服的果糖显示出比葡萄糖更弱的内分泌反应,这表明化学特异性.
结论:
- 开发的老鼠制剂有效地表征了口服刺激的内分泌反应.
- 葡萄糖是主要的单糖,通过口服刺激引发循环胰岛素的早期增加.
- 这些发现强调了口服途径在启动关键代谢激素反应方面的重要性.
相关概念视频
Glucagon-like Receptor Agonists
435
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
435
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
Insulin Formulations: Types and Delivery
277
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
277
Insulin: Dosing Regimen and Adverse Effects
270
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
270
Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
Hormones Regulating Blood Glucose
4.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.1K


